Stockscreener 앱 받기
69.89
3.14%
2.13
시간 외 거래:
69.89
전일 마감가:
$67.76
열려 있는:
$67.63
하루 거래량:
6.96M
Relative Volume:
1.19
시가총액:
$40.52B
수익:
$6.60B
순이익/손실:
$4.16B
주가수익비율:
29.87
EPS:
2.34
순현금흐름:
$490.10M
1주 성능:
+4.78%
1개월 성능:
-0.54%
6개월 성능:
-21.60%
1년 성능:
+4.47%
1일 변동 폭
$67.58
$71.08
1주일 범위
$64.89
$71.08
52주 변동 폭
$58.93
$96.12
에드워즈라이프사이언시스 Stock (EW) Company Profile
명칭
Edwards Lifesciences Corp
전화
(949) 250-2500
주소
ONE EDWARDS WAY, IRVINE, CA
EW을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| EW | 69.89 | 40.52B | 6.60B | 4.16B | 490.10M | 2.34 |
| ABT | 117.36 | 202.64B | 41.22B | 5.77B | 6.49B | 2.94 |
| SYK | 389.40 | 150.72B | 21.97B | 3.59B | 3.21B | 6.74 |
| BSX | 90.45 | 133.82B | 15.91B | 1.79B | 1.89B | 0.82 |
| MDT | 87.59 | 112.98B | 32.58B | 3.93B | 5.15B | 2.71 |
에드워즈라이프사이언시스 Stock (EW) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-10-11 | 재개 | Morgan Stanley | Equal-Weight |
| 2024-09-18 | 다운그레이드 | Jefferies | Buy → Hold |
| 2024-07-31 | 업그레이드 | Daiwa Securities | Neutral → Outperform |
| 2024-07-29 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2024-07-25 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2024-07-25 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-07-25 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-07-25 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2024-07-25 | 다운그레이드 | Truist | Buy → Hold |
| 2024-05-30 | 개시 | Goldman | Buy |
| 2024-05-22 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-05-14 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2024-03-07 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2024-02-02 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-01-04 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2023-12-11 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2023-11-28 | 다운그레이드 | Wolfe Research | Peer Perform → Underperform |
| 2023-09-26 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2023-07-19 | 개시 | Robert W. Baird | Outperform |
| 2023-05-30 | 재개 | Morgan Stanley | Overweight |
| 2023-03-29 | 개시 | UBS | Neutral |
| 2023-03-08 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2023-02-06 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2023-01-31 | 다운그레이드 | Bernstein | Outperform → Underperform |
| 2023-01-30 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-12-06 | 다운그레이드 | Stifel | Buy → Hold |
| 2022-10-28 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2022-10-26 | 개시 | Mizuho | Buy |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-07-29 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2022-04-13 | 개시 | Truist | Buy |
| 2022-04-06 | 개시 | Wolfe Research | Outperform |
| 2022-03-16 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
| 2022-03-02 | 재개 | BofA Securities | Neutral |
| 2022-02-02 | 업그레이드 | UBS | Neutral → Buy |
| 2022-01-27 | 재확인 | Citigroup | Buy |
| 2022-01-27 | 재확인 | Evercore ISI | Outperform |
| 2022-01-27 | 재확인 | Raymond James | Outperform |
| 2022-01-27 | 재확인 | Stifel | Buy |
| 2022-01-27 | 재확인 | UBS | Neutral |
| 2021-12-17 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2021-12-15 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-12-10 | 개시 | RBC Capital Mkts | Outperform |
| 2021-12-06 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2021-07-30 | 재확인 | Canaccord Genuity | Buy |
| 2021-07-30 | 재확인 | Deutsche Bank | Hold |
| 2021-07-30 | 재확인 | Jefferies | Buy |
| 2021-07-30 | 재확인 | Morgan Stanley | Overweight |
| 2021-07-30 | 재확인 | Oppenheimer | Outperform |
| 2021-07-30 | 재확인 | Stifel | Buy |
| 2021-07-30 | 재확인 | UBS | Neutral |
| 2021-07-30 | 재확인 | Wells Fargo | Equal Weight |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-15 | 개시 | Atlantic Equities | Neutral |
| 2021-04-05 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2020-12-16 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2020-12-11 | 재확인 | Canaccord Genuity | Buy |
| 2020-09-11 | 개시 | Wolfe Research | Underperform |
| 2020-04-28 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2020-04-17 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2020-02-13 | 개시 | Goldman | Neutral |
| 2020-02-06 | 재개 | BTIG Research | Neutral |
| 2020-01-10 | 개시 | Oppenheimer | Outperform |
| 2020-01-02 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2019-10-24 | 재확인 | Canaccord Genuity | Buy |
| 2019-09-23 | 개시 | Piper Jaffray | Overweight |
| 2019-07-24 | 재확인 | BofA/Merrill | Buy |
| 2019-03-18 | 재확인 | Canaccord Genuity | Buy |
| 2019-01-18 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-01-03 | 개시 | Deutsche Bank | Hold |
| 2018-11-28 | 개시 | UBS | Neutral |
| 2018-10-16 | 개시 | Barclays | Underweight |
| 2018-10-02 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2018-10-02 | 다운그레이드 | Guggenheim | Buy → Neutral |
모두보기
에드워즈라이프사이언시스 주식(EW)의 최신 뉴스
Edwards Lifesciences Corporation Sued for Securities Law ViolationsInvestors Should Contact The Gross Law Firm for More InformationEW - Marketscreener.com
Edwards Lifesciences wins Meril injunction as pro-patentee decisions continue to flow from UPC - IAM
Edwards deals a severe blow to Meril with regular advisors - JUVE Patent
Kessler Topaz Meltzer & Check, LLP Notifies Edwards Lifesciences Corporation Investors of Upcoming Deadline in Securities Fraud Class Action Lawsuit - GlobeNewswire Inc.
S&CO Inc. Has $4.06 Million Stock Holdings in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
2024-11-17 | DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Edwards Lifesciences Corporation | NYSE:EW | Press Release - Stockhouse Publishing
Edwards Lifesciences quarterly net falls on charge - Reuters.com
Ipswich Investment Management Co. Inc. Cuts Holdings in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Edwards Lifesciences Corp Class Action: Lead Plaintiff Deadline is 12/13/24; Contact Robbins LLP for Information - Benzinga
Edwards Lifesciences Corp Class Action: Lead Plaintiff Deadline is 12/13/24; Contact Robbins LLP for - EIN News
Edwards Lifesciences Corp. stock outperforms competitors on strong trading day - MarketWatch
EW COURT REPORT: A Class Action has been Filed Against Edwards Lifesciences, Investors are Urged to Contact BFA Law by December 13 Deadline - Newsfile
Edwards Lifesciences (EW) Faces Investor Class Action Over Loss of $16 Billion Of Market CapitalizationHagens Berman - Marketscreener.com
Huntington National Bank Lowers Position in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
KBC Group NV Has $59.14 Million Holdings in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Finansavisen - Finansavisen
EW Announcement: Kessler Topaz Meltzer & Check, LLP Encourages Edwards Lifesciences Corporation Investors to Contact the Firm About Securities Fraud Class Action Lawsuit - Markets Insider
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Edwards Lifesciences Corporation - Marketscreener.com
Edwards Lifesciences Corp (EW-N) QuotePress Release - The Globe and Mail
Edwards Lifesciences Corp. stock outperforms competitors despite losses on the day - MarketWatch
EW INVESTOR NOTICE: Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit – Company AnnouncementFT.com - Financial Times
United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund Raises Stock Position in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Shareholders of Edwards Lifesciences Corporation Should Contact The Gross Law Firm Before December 13, 2024 to Discuss Your RightsEW - Marketscreener.com
Edwards Lifesciences exec Donald Bobo Jr sells $327,843 in stock - Investing.com
Edwards Lifesciences' SWOT analysis: heart valve maker's stock faces growth challenges - Investing.com
EW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit with the Schall Law Firm - Marketscreener.com
Baillie Gifford & Co. Cuts Holdings in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
EW LEGAL NOTICE: Edwards Lifesciences Investors are Notified to Contact BFA Law before Expiration of December 13 Class Action Deadline - Newsfile
We Like The Quality Of Edwards Lifesciences' (NYSE:EW) Earnings - Yahoo Finance
EDWARDS ALERT: Bragar Eagel & Squire, P.C. Reminds - GlobeNewswire
Edwards Lifesciences Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
EDWARDS LIFESCIENCES CORPORATION (NYSE: EW) INVESTOR ALERT: - GlobeNewswire
GDS Wealth Management Cuts Stake in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Patten & Patten Inc. TN Has $10.88 Million Stake in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
The Gross Law Firm Notifies Shareholders of Edwards Lifesciences Corporation(EW) of a Class Action Lawsuit and an Upcoming Deadline - Marketscreener.com
ROSEN, A TOP-RANKED LAW FIRM, Encourages Edwards - GlobeNewswire
ROSEN, A TOP-RANKED LAW FIRM, Encourages Edwards Lifesciences Corporation Investors to Secure - The Bakersfield Californian
Edwards Lifesciences Corporation (EW) Investors: December 13, 2024 Filing Deadline in Securities Class ActionContact Kessler Topaz Meltzer & Check, LLP - Marketscreener.com
EW INVESTOR ALERT: Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit – Company AnnouncementFT.com - Financial Times
2024-11-10 | SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Edwards Lifesciences Corporation | NYSE:EW | Press Release - Stockhouse Publishing
Edwards Lifesciences Co. (NYSE:EW) Stock Position Increased by Ownership Capital B.V. - MarketBeat
10,110 Shares in Edwards Lifesciences Co. (NYSE:EW) Acquired by Objective Capital Management LLC - MarketBeat
Townsend & Associates Inc Purchases 8,441 Shares of Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Equitable Trust Co. Grows Stock Position in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
EW SHAREHOLDERS: Investors in Edwards Lifesciences (EW) that Lost Money when Stock Plummeted 31% are Urged to Contact BFA Law about the Class Action Lawsuit - Newsfile
Decoding Edwards Lifesciences Corp (EW): A Strategic SWOT Insigh - GuruFocus.com
Decoding Edwards Lifesciences Corp (EW): A Strategic SWOT Insight - Yahoo Finance
Edwards Lifesciences Corp. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Wellington Management Group LLP's Strategic Acquisition of Edwards Lifesciences Corp Shares - GuruFocus.com
EW Announcement: Contact Kessler Topaz Meltzer & Check, LLP About the Securities Fraud Class Action Lawsuit Filed Against Edwards Lifesciences Corporation - Markets Insider
AIA Group Ltd Purchases 358,556 Shares of Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
에드워즈라이프사이언시스 (EW) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.17%
1.38%
자본화:
|
볼륨(24시간):